Eliquis litigation
Claims allege that the blood thinner Eliquis caused serious, sometimes fatal bleeding events, and that early marketing overstated its safety.
Free case review
What the claims allege
Eliquis (apixaban) launched without an approved reversal agent, meaning serious bleeds were difficult to stop. Claims allege patients were not adequately warned about that limitation or about questions raised over the conduct of the drug’s pivotal trial.
Injuries named in the litigation
- Gastrointestinal hemorrhage
- Intracranial bleeding
- Bleeding requiring hospitalization or transfusion
Who may qualify
If you or a family member suffered a major bleeding event while taking Eliquis, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.